This information collection request covers the reporting and recordkeeping
provisions associated with FDA's implementation of sections 222, 223, and 224 of the
Food and Drug Administration Amendments Act of 2007 (FDAAA), which require that
device establishment registrations and listings under section 21 U.S.C. 360(p)
(including the submission of updated information) be submitted to the Secretary by
electronic means, unless the Secretary grants a request for waiver of the
requirement because the use of electronic means is not reasonable for the person
requesting the waiver.
There has been an adjustment in the burden hours and annual responses for this collection. FDA attributes the increase in burden to the additional information that must be submitted to comply with FDAAA. FDA attributes the decrease in responses to more accurate estimates. Prior to the electronic system, registrants were not deleted from they rolls unless an FDA District Office confirmed that the registrant was no longer in business. Under the system currently in place, potential registrants were notified that they must confirm their registrations or they would be deleted from the system.
$1,528,775
No
No
No
No
No
Uncollected
Daniel Gitteson 3017965156 daniel.gitteson@fda.hhs.gov
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.